Tengfei Fan

Dr. Tengfei Fan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2024 in Phytomedicine
Verified
Journal Article
Closed access
YPYong-Chun Peng
Yong-Chun Peng
ZHZhi-Jing He
Zhi-Jing He
LYLun-Cai Yin
Lun-Cai Yin
HPHui-Feng Pi
Hui-Feng Pi
YJYi Jiang
Yi Jiang
TFTengfei Fan
Tengfei Fan

19 January 2023 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
YPYongchun Peng
Yongchun Peng
DYDanhui Yin
Danhui Yin
XLXiaoxuan Li
Xiaoxuan Li
KWKai Wang
Kai Wang
WLWei Li
Wei Li
TFTengfei Fan
Tengfei Fan

26 August 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
DYDanhui Yin
Danhui Yin
QYQian Yang
Qian Yang
SLShisheng Li
Shisheng Li
YPYongchun Peng
Yongchun Peng
JZJianbo Zhang
Jianbo Zhang
TFTengfei Fan
Tengfei Fan
Head and neck squamous cell carcinoma (HNSCC) has a high rate of metastasis and recurrence, and poses a considerable threat to patient survival. Autophagy, an intracellular degradation pathway, plays a crucial role in tumor progression; however, the underlying mechanisms of action remain unclear. This study aimed to explore the role of the ACSS2-TFEB axis in the regulation of autophagy and its impact on HNSCC cell proliferation, migration, invasion, and lysosomal function. HNSCC tumor tissues and cell lines were analyzed for ACSS2 protein expression. The effects of the ACSS2 knockdown on cell proliferation, migration, invasion, and autophagic flux were also assessed. The interaction between ACSS2 and transcription factor EB (TFEB) and its influence on lysosomal function were also examined. In this study, we found that ACSS2 protein expression was significantly upregulated and correlated with metastasis and poor prognosis. ACSS2 knockdown inhibited the proliferation, migration, and invasion of HNSCC cells, and disrupted autophagy flux, primarily by impairing lysosomal function. Additionally, ACSS2 was found to sustain autophagic flux through TFEB activation, a key regulator of the autophagy-lysosome pathway. TFEB activation promotes lysosomal function and autophagic flux, thereby facilitating tumor cell growth and metastasis. This study elucidated the molecular mechanism by which ACSS2 enhances HNSCC cell proliferation and invasion via TFEB activation. The ACSS2-TFEB axis is a potential therapeutic target for HNSCC and provides a foundation for the development of targeted therapies.

8 September 2025 in Advanced Science
Verified
Journal Article
Open access
JLJingdian Li
Jingdian Li
PDPing Deng
Ping Deng
TFTengfei Fan
Tengfei Fan
YQYuchen Qu
Yuchen Qu
MTMiduo Tan
Miduo Tan
HPHuifeng Pi
Huifeng Pi
Cadmium (Cd) is a heavy metal that exhibits strong carcinogenic properties and promotes breast cancer (BC) progression. Autophagic flux dysfunction is involved in Cd‐induced BC progression, but the underlying molecular mechanisms remain unclear. Here, it is observed that impaired autophagic flux and metabolic reprogramming are notable features related to Cd‐induced proliferation, migration, and invasion in BC cell lines, including T‐47D and MCF‐7 cells. Through the integration of metabolomics, proteomics, and ingenuity pathway analysis, a metabolite–protein regulatory network is constructed, which revealed that 5′‐methylthioadenosine (MTA)‐mediated metabolic reprogramming plays a core regulatory role in the epigenetic‒autophagy axis involved in Cd‐induced autophagic flux impairment and BC progression. Mechanistically, Cd‐induced MTA depletion specifically increased DOT1L methyltransferase activity and H3K79me1 levels in the PAK2 promoter region, inducing the expression of PAK2 , which contributed to the autophagic flux blockade required for BC progression in Cd‐exposed BC cells and transgenic MMTV‐ErbB2 mice. Clinically, a significant negative correlation is also verified between MTA levels and TNM stage in BC patients; that is, advanced‐stage tumors exhibited notably lower MTA levels than early‐stage tumors. Thus, the study provides insights into metabolism‒epigenetic crosstalk in the context of Cd‐induced BC progression and highlights the importance of considering environmental factors in cancer healthcare.

27 February 2025 in Cancer Science
Verified
Journal Article
Open access
YPYongchun Peng
Yongchun Peng
JZJianbo Zhang
Jianbo Zhang
HGHaoxuan Guo
Haoxuan Guo
ZHZhijing He
Zhijing He
YJYi Jiang
Yi Jiang
TFTengfei Fan
Tengfei Fan
Oral squamous cell carcinoma (OSCC) is a prevalent type of head and neck neoplasm distinguished by a high risk of metastasis and a poor prognosis. Nevertheless, the fundamental mechanisms of OSCC cell proliferation and metastasis remain poorly understood. Autophagy, as the principal intracellular degradation system, has been implicated in OSCC progression; however, its underlying mechanism remains unclear. In this study, transcriptomic sequencing analysis was performed using both The Cancer Genome Atlas (TCGA) database and samples from OSCC patients and revealed significant upregulation of EPHB2 expression, which is positively correlated with OSCC metastasis and a poor prognosis. In subsequent studies, we observed that the knockdown of EPHB2 resulted in the blockade of autophagic flux due to impaired lysosomal function, leading to inhibited proliferation, migration, and invasion in OSCC cells. Furthermore, the knockdown of EPHB2 significantly suppressed the expression of VPS4A, a key mediator that facilitates autolysosomal degradation. The overexpression of VPS4A restored lysosomal function and autophagic flux, thereby attenuating the inhibitory effects of EPHB2 knockdown on OSCC cell progression. The findings of this study demonstrate that the molecular mechanism underlying EPHB2 regulation of autophagic flux to promote OSCC progression is by regulating VPS4A activity and that EPHB2 may be a diagnostic biomarker and therapeutic target for OSCC prevention and treatment.

1 April 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
YYYuan Yuan
Yuan Yuan
TFTengfei Fan
Tengfei Fan
JWJingbo Wang
Jingbo Wang
YYYing Yuan
Ying Yuan
XTXiaofeng Tao
Xiaofeng Tao
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with 890,000 new cases and 450,000 deaths as of 2018.1 The five-year relative survival rate for head and neck tumors ranged from 53% in 1970 to 67% in 2010.2 The survival rate for the early stages of the disease is 80%, but only 20% to 60% for the late stages.3 The survival rates have not improved significantly over the years due to various shortcomings. First, because of the insidious location of head and neck cancer, most patients are already in the progressive stage (tumor, node, and metastasis stage III-IV) at the initial diagnosis. Second, because of the deep anatomical location of the onset and infiltrating tissues of the lesion connecting the blood vessels and nerves, complete surgical resection (R0 resection) is difficult. Therefore, early diagnosis and improved surgical precision for resection are required to reduce recurrence and improve patient prognosis.